Literature DB >> 27489019

Predictors of community-associated Staphylococcus aureus, methicillin-resistant and methicillin-susceptible Staphylococcus aureus skin and soft tissue infections in primary-care settings.

G C Lee1, R G Hall2, N K Boyd1, S D Dallas3, L C Du4, L B Treviño4, C Retzloff4, S B Treviño4, K A Lawson1, J P Wilson1, R J Olsen5, Y Wang6, C R Frei1.   

Abstract

Skin and soft tissue infections (SSTIs) due to Staphylococcus aureus have become increasingly common in the outpatient setting; however, risk factors for differentiating methicillin-resistant S. aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) SSTIs are needed to better inform antibiotic treatment decisions. We performed a case-case-control study within 14 primary-care clinics in South Texas from 2007 to 2015. Overall, 325 patients [S. aureus SSTI cases (case group 1, n = 175); MRSA SSTI cases (case group 2, n = 115); MSSA SSTI cases (case group 3, n = 60); uninfected control group (control, n = 150)] were evaluated. Each case group was compared to the control group, and then qualitatively contrasted to identify unique risk factors associated with S. aureus, MRSA, and MSSA SSTIs. Overall, prior SSTIs [adjusted odds ratio (aOR) 7·60, 95% confidence interval (CI) 3·31-17·45], male gender (aOR 1·74, 95% CI 1·06-2·85), and absence of healthcare occupation status (aOR 0·14, 95% CI 0·03-0·68) were independently associated with S. aureus SSTIs. The only unique risk factor for community-associated (CA)-MRSA SSTIs was a high body weight (⩾110 kg) (aOR 2·03, 95% CI 1·01-4·09).

Entities:  

Keywords:  zzm321990 Staphylococcus aureuszzm321990 ; Epidemiology; soft tissue infections

Mesh:

Year:  2016        PMID: 27489019      PMCID: PMC9150203          DOI: 10.1017/S0950268816001709

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  7 in total

Review 1.  The case-case-control study design: addressing the limitations of risk factor studies for antimicrobial resistance.

Authors:  Keith S Kaye; Anthony D Harris; Matthew Samore; Yehuda Carmeli
Journal:  Infect Control Hosp Epidemiol       Date:  2005-04       Impact factor: 3.254

2.  Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: a prospective investigation.

Authors:  Loren G Miller; Franciose Perdreau-Remington; Arnold S Bayer; Binh Diep; Nelly Tan; Kiran Bharadwa; Jennifer Tsui; Joshua Perlroth; Anthony Shay; Grace Tagudar; Uzoma Ibebuogu; Brad Spellberg
Journal:  Clin Infect Dis       Date:  2007-01-19       Impact factor: 9.079

3.  Treatment failure and costs in patients with methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections: a South Texas Ambulatory Research Network (STARNet) study.

Authors:  Matthew J Labreche; Grace C Lee; Russell T Attridge; Eric M Mortensen; Jim Koeller; Liem C Du; Natalie R Nyren; Lucina B Treviño; Sylvia B Treviño; Joel Peña; Michael W Mann; Abilio Muñoz; Yolanda Marcos; Guillermo Rocha; Stella Koretsky; Sandra Esparza; Mitchell Finnie; Steven D Dallas; Michael L Parchman; Christopher R Frei
Journal:  J Am Board Fam Med       Date:  2013 Sep-Oct       Impact factor: 2.657

4.  Prevalence, severity, and treatment of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) skin and soft tissue infections in 10 medical clinics in Texas: a South Texas Ambulatory Research Network (STARNet) study.

Authors:  Nicolas A Forcade; Michael L Parchman; James H Jorgensen; Liem C Du; Natalie R Nyren; Lucina B Treviño; Joel Peña; Michael W Mann; Abilio Muñoz; Sylvia B Treviño; Eric M Mortensen; Brian L Wickes; Brad H Pollock; Christopher R Frei
Journal:  J Am Board Fam Med       Date:  2011 Sep-Oct       Impact factor: 2.657

5.  Community-associated methicillin-resistant Staphylococcus aureus and HIV: intersecting epidemics.

Authors:  Kyle J Popovich; Robert A Weinstein; Alla Aroutcheva; Thomas Rice; Bala Hota
Journal:  Clin Infect Dis       Date:  2010-04-01       Impact factor: 9.079

6.  Oritavancin population pharmacokinetics in healthy subjects and patients with complicated skin and skin structure infections or bacteremia.

Authors:  Christopher M Rubino; Scott A Van Wart; Sujata M Bhavnani; Paul G Ambrose; Jill S McCollam; Alan Forrest
Journal:  Antimicrob Agents Chemother       Date:  2009-07-27       Impact factor: 5.191

7.  Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus.

Authors:  Daniel J Pallin; Daniel J Egan; Andrea J Pelletier; Janice A Espinola; David C Hooper; Carlos A Camargo
Journal:  Ann Emerg Med       Date:  2008-01-28       Impact factor: 5.721

  7 in total
  2 in total

1.  Emerging multidrug resistance in community-associated Staphylococcus aureus involved in skin and soft tissue infections and nasal colonization.

Authors:  Grace C Lee; Steven D Dallas; Yufeng Wang; Randall J Olsen; Kenneth A Lawson; James Wilson; Christopher R Frei
Journal:  J Antimicrob Chemother       Date:  2017-09-01       Impact factor: 5.790

2.  Is community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) an emerging pathogen among children in Brazil?

Authors:  Rolando Paternina-de la Ossa; Seila Israel do Prado; Maria Célia Cervi; Denissani Aparecida Ferrari Dos Santos Lima; Roberto Martinez; Fernando Bellissimo-Rodrigues
Journal:  Braz J Infect Dis       Date:  2018-10-30       Impact factor: 3.257

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.